Biomarker-guided Repurposing
Biomarker-Guided Repurposing is a drug repurposing strategy that systematically uses predictive molecular or clinical biomarkers to identify new therapeutic indications and responsive patient subpopulations for already approved drugs, particularly chemotherapeutic agents.
26
Publications
1.7K
Citations
211
Authors
111
Institutions
Publications per year
2017–2026
19
26
Drug repurposing from an academic perspective
Tudor I. Oprea, Julie E. Bauman, Cristian Bologa et al. · Drug Discovery Today Therapeutic Strategies · 2011 · 369 citations
Machine learning identifies candidates for drug repurposing in Alzheimer’s disease
Steve Rodriguez, Clemens B. Hug, Petar V. Todorov et al. · Nature Communications · 2021 · 297 citations · Full text
Drug Repurposing: Far Beyond New Targets for Old Drugs
Tudor I. Oprea, Jordi Mestres · The AAPS Journal · 2012 · 291 citations · Full text
1–5 of 26
211
2
h-index
2
h-index
2
h-index
2
h-index
1
h-index
1–5 of 211
111
Universitätsmedizin Göttingen
Göttingen, Germany
3 h-index
3 publications
111 citations
University of New Mexico
Albuquerque, United States
2 h-index
27 publications
9.9K citations
Berlin Institute of Health at Charité - Universitätsmedizin Berlin
Berlin, Germany
2 h-index
5 publications
204 citations
Charité - Universitätsmedizin Berlin
Berlin, Germany
2 h-index
14 publications
514 citations
Technical University of Denmark
Kongens Lyngby, Denmark
2 h-index
2 publications
660 citations
Duke University
Durham, United States
2 h-index
4 publications
71 citations
Berlin-Brandenburger Centrum für Regenerative Therapien
Berlin, Germany
2 h-index
3 publications
112 citations

University of Groningen
Groningen, The Netherlands
2 h-index
7 publications
288 citations
1–8 of 111
2 publications · 120 citations
2
h-index
JACC · 2 publications · 79 citations
2
h-index
2 publications · 66 citations
2
h-index
1 publications · 297 citations
2
h-index
1 publications · 36 citations
2
h-index
1–5